ADMA insider transaction filings

ADMA BIOLOGICS, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-28. Screen ADMA transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-284Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 3,177 @ $8.37EDGAR
2026-07-174Kohler Terry — CFO and TreasurerGrant/award (A): 85,130 @ $0 · Grant/award (A): 136,363 (derivative) @ $0EDGAR
2026-05-284Grossman Jerrold B — DirectorPurchase (P): 6,400 @ $7.91EDGAR
2026-05-144Grossman Jerrold B — DirectorPurchase (P): 12,500 @ $8.01EDGAR
2026-05-124Grossman Jerrold B — DirectorPurchase (P): 12,500 @ $8.01EDGAR
2026-04-034Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 20,362 @ $9.11EDGAR
2026-03-174Guiheen Lawrence P. — DirectorOption exercise (M): 30,000 @ $3.66 · Gift (G): 30,000 @ $0 · Gift (G): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2026-03-174Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $15.16 · Sale (S): 6,000 @ $15.16 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-03-104Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 10,059 @ $15.39 · Tax withholding (F): 4,235 @ $15.39 · Other (J): 91,266 @ $0 · Option exercise (M): 2,500 @ $5 · Option exercise (M): 1,250 @ $4.31 · Option exercise (M): 2,646 @ $2.83 · +8 moreEDGAR
2026-03-104Grossman Adam S — President and CEO, DirectorTax withholding (F): 56,438 @ $15.39 · Tax withholding (F): 29,513 @ $15.39EDGAR
2026-03-094ELMS STEVE — DirectorPurchase (P): 7,000 @ $15.67 · Purchase (P): 7,000 @ $15.39EDGAR
2026-03-024Grossman Adam S — President and CEO, DirectorTax withholding (F): 54,858 @ $15.18EDGAR
2026-02-234Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 8,161 @ $16.32EDGAR
2026-02-234Grossman Adam S — President and CEO, DirectorTax withholding (F): 24,793 @ $16.32EDGAR
2026-02-234Tade Brad L. — CFO and TreasurerTax withholding (F): 6,479 @ $16.32EDGAR
2026-02-174Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16.08 · Sale (S): 6,000 @ $16.08 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-02-114Grossman Jerrold B — DirectorGrant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0EDGAR
2026-02-114Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceGrant/award (A): 91,631 @ $0 · Grant/award (A): 144,230 (derivative) @ $0EDGAR
2026-02-114Grossman Adam S — President and CEO, DirectorGrant/award (A): 282,529 @ $0 · Grant/award (A): 444,711 (derivative) @ $0EDGAR
2026-02-114KWON YOUNG — DirectorGrant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0EDGAR
2026-02-114FINGER ALISON CECILY — DirectorGrant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0EDGAR
2026-02-114Salas Eduardo Rene — DirectorGrant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0EDGAR
2026-02-114Guiheen Lawrence P. — DirectorGrant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0EDGAR
2026-02-114ELMS STEVE — DirectorGrant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0EDGAR
2025-12-164Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $19.79 · Sale (S): 6,000 @ $19.79 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-11-214Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16 · Sale (S): 6,000 @ $16 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-10-244Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16 · Sale (S): 6,000 @ $16 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-09-164Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16.13 · Sale (S): 6,000 @ $16.13 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-08-154Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16.88 · Sale (S): 6,000 @ $16.88 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-08-014Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceOption exercise (M): 2,500 @ $8.98 · Tax withholding (F): 1,208 @ $18.59 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2025-07-284Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 3,027 @ $17.31EDGAR
2025-07-284Tade Brad L. — CFO and TreasurerTax withholding (F): 7,123 @ $17.31EDGAR
2025-07-164Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $18.66 · Sale (S): 6,000 @ $18.66 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-06-304Tade Brad L. — CFO and TreasurerTax withholding (F): 9,838 @ $18.40EDGAR
2025-06-184Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $20.81 · Sale (S): 6,000 @ $20.81 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-06-164ELMS STEVE — DirectorSale (S): 92,941 @ $21.69 · Option exercise (M): 9,000 @ $5.96 · Option exercise (M): 10,000 @ $5 · Option exercise (M): 53,837 @ $3.66 · Option exercise (M): 17,500 @ $4.91 · Option exercise (M): 30,000 @ $3.89 · +17 moreEDGAR
2025-06-114Guiheen Lawrence P. — DirectorSale (S): 20,000 @ $20.96EDGAR
2025-06-104Grossman Jerrold B — DirectorOption exercise (M): 10,000 @ $5 · Sale (S): 10,000 @ $21.31 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2025-05-234Guiheen Lawrence P. — DirectorOption exercise (M): 7,779 @ $5.96 · Sale (S): 7,779 @ $20.32 · Option exercise (M): 1,221 @ $5.96 · Sale (S): 1,221 @ $20.12 · Option exercise (M): 7,779 (derivative) @ $0 · Option exercise (M): 1,221 (derivative) @ $0EDGAR
2025-05-164Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $19.45 · Sale (S): 6,000 @ $19.45 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-04-164Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $21.46 · Sale (S): 6,000 @ $21.46 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-04-024Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 18,920 @ $19.42EDGAR
2025-03-214Grossman Adam S — President and CEO, DirectorOption exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $18.92 · Sale (S): 6,000 @ $18.92 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-03-104Grossman Adam S — President and CEO, DirectorTax withholding (F): 56,438 @ $16.91 · Tax withholding (F): 29,513 @ $17.02EDGAR
2025-03-104Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 8,881 @ $16.91 · Tax withholding (F): 3,935 @ $17.02EDGAR
2025-02-274Grossman Adam S — President and CEO, DirectorTax withholding (F): 18,018 @ $15.44 · Tax withholding (F): 54,867 @ $15.78EDGAR
2025-02-274Kestenberg-Messina Kaitlin M. — COO and SVP, ComplianceTax withholding (F): 1,855 @ $15.44EDGAR
2025-02-274Tade Brad L. — CFO and TreasurerTax withholding (F): 5,280 @ $15.78EDGAR
2025-02-214Guiheen Lawrence P. — DirectorGrant/award (A): 10,889 @ $0 · Grant/award (A): 16,279 (derivative) @ $0EDGAR
2025-02-214KWON YOUNG — DirectorGrant/award (A): 10,889 @ $0 · Grant/award (A): 16,279 (derivative) @ $0EDGAR

Recent 8-K events — ADMA BIOLOGICS, INC.

FiledFormItems reportedSource
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-278-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-028-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-258-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-068-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ADMA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →